HR 941 · 117th Congress · Health

TRANSPLANT Act of 2021

Introduced 2021-02-08· Sponsored by Rep. Matsui, Doris O. [D-CA-6]· House

Bill Progress

1
Introduced
Committee
House Vote
Senate
Enacted
Latest: Became Public Law No: 117-15.(2021-05-26)

Recorded Votes

PassedHouse · 2021-04-15
Roll #109
Yea 415Nay 2
Democrats
215 Yea·0 Nay
Republicans
200 Yea·2 Nay
PassedHouse · 2021-04-15
Roll #109
Yea 415Nay 2
Democrats
215 Yea·0 Nay
Republicans
200 Yea·2 Nay

How Did Your Rep Vote?

Enter a ZIP code or representative's name

Plain Language Summary

[AI summary unavailable — showing source text] Timely ReAuthorization of Necessary Stem-cell Programs Lends Access to Needed Therapies Act of 2021 or the TRANSPLANT Act of 2021 This bill modifies and reauthorizes through FY2026 the C.W. Bill Young Cell Transplantation Program, which provides support to patients who need a potentially life-saving bone marrow transplant or umbilical cord blood transplant. The bill also requires the Department of Health and Human Services to conduct a periodic review of the science of using adult stem cells and birthing tissues in therapeutic treatments. In addition, the Government Accountability Office must report on the regenerative medicine workforce.…

Summarized by Claude AI · Non-partisan · For informational purposes only

Cosponsors (20)

15 Democrats5 Republicans